Group 1 - The technology sector is a significant component of the NASDAQ index, encompassing software and application services, computer hardware, semiconductor chips, internet technology, and social media, with a focus on technological innovation driving the digital economy [1] - The healthcare industry holds a notable share in the NASDAQ index, including biotechnology research, medical device manufacturing, healthcare services, and pharmaceuticals, closely linked to global medical demand and research advancements [1] - The consumer sector is also represented in the NASDAQ index, involving retail trade, e-commerce platforms, and daily consumer goods manufacturing, directly addressing consumer needs through diverse products and services [1] Group 2 - The financial and industrial sectors are part of the NASDAQ index, with financial companies focusing on fintech, payment solutions, and asset management, while industrial firms cover aerospace, renewable energy equipment manufacturing, and industrial automation [2] - The NASDAQ index showcases a diversified industry composition, reflecting both emerging sectors like technology and traditional industries such as consumer and industrial, providing a comprehensive view of growth and innovation in the U.S. capital market [2] - This diversity in industry structure offers market participants valuable insights into the development status of related companies and highlights the capital market's acceptance of innovation and growth potential across different sectors [2]

通过天眼查大数据分析，上海万何圆生物科技有限公司共对外投资了7家企业，知识产权方面有商标信 息27条，专利信息38条，此外企业还拥有行政许可8个。 天眼查信息显示，上海万何圆生物科技有限公司的股东为：边学敏、费新容、康敏、上海锲不舍生物科 技中心（有限合伙）、上海锲圆生物科技有限公司。 来源：市场资讯 1月22日，天眼查融资历程显示，上海万何圆生物科技有限公司近日获得"A轮"融资，涉及融资金额数 千万人民币，投资机构为金沙江联合资本，容亿投资，合肥产投国正。 资料显示，上海万何圆生物科技有限公司法定代表人为许亚苏，成立于2020年，位于上海市，是一家以 从事研究和试验发展为主的企业。企业注册资本753.035万人民币，并已于2026年完成了A轮，交易金额 数千万人民币。 ...

通过天眼查大数据分析，艾比欧义（杭州）生物科技有限公司共对外投资了2家企业，知识产权方面有 商标信息15条，专利信息6条，此外企业还拥有行政许可3个。 天眼查信息显示，艾比欧义（杭州）生物科技有限公司的股东为：刘大鹏、上海度比科企业管理咨询合 伙企业（有限合伙）、上海壹熵跃盈企业咨询合伙企业（有限合伙）、深圳度比科企业管理咨询合伙企 业（有限合伙）、杭州科丽欧美生物科技有限公司。 来源：市场资讯 1月16日，天眼查融资历程显示，艾比欧义（杭州）生物科技有限公司近日获得"Pre-A轮"融资，涉及融 资金额数千万人民币，投资机构为浦东创投集团旗下AI种子基金参与完成艾比欧义数千万元Pre-A轮融 资。 资料显示，艾比欧义（杭州）生物科技有限公司法定代表人为刘大鹏，成立于2024年，位于杭州市，是 一家以从事研究和试验发展为主的企业。企业注册资本120.6666万人民币，并已于2026年完成了Pre-A 轮，交易金额数千万人民币。 ...

1月13日，天眼查融资历程显示，华清智美（深圳）生物科技有限公司近日获得"A轮"融资，涉及融资 金额数千万人民币，投资机构为生物3D打印硬核创新引领变革，华清智美凭全球领先技术斩获数千万A 轮融资！。 资料显示，华清智美（深圳）生物科技有限公司法定代表人为刘博勋，成立于2021年，位于深圳市，是 一家以从事研究和试验发展为主的企业。企业注册资本837.88063万人民币，并已于2026年完成了A轮， 交易金额数千万人民币。 通过天眼查大数据分析，华清智美（深圳）生物科技有限公司共对外投资了2家企业，知识产权方面有 商标信息121条，专利信息33条，此外企业还拥有行政许可17个。 天眼查信息显示，华清智美（深圳）生物科技有限公司的股东为：深圳市众光和明科技合伙企业（有限 合伙）、刘博勋、深圳市通光达明科技合伙企业（有限合伙）、李根、百盈悦（海南）投资有限公司。 来源：市场资讯 ...

本报讯(记者袁传玺)天眼查App显示，12月25日，上海启生元生命科技有限公司成立，注册资本5亿元， 经营范围包括生物化工产品技术研发、生物农药技术研发等，由中国烟草投资管理公司、北京生命科技 研究院有限公司、上海烟草集团有限责任公司共同持股。 ...

Core Viewpoint - Wuxi Shibo Rui Biotechnology Co., Ltd. has been established with a registered capital of 100,000 RMB, focusing on various technology services and sales in the food and agricultural sectors [1] Company Overview - The legal representative of the company is Su Ziwen [1] - The registered capital is 100,000 RMB [1] Business Scope - The company engages in technology services, development, consulting, exchange, transfer, and promotion [1] - It is involved in the research and development of biological feed and the sale of pre-packaged food [1] - The company also sells health food (pre-packaged), feed additives, feed raw materials, and engages in the purchase and sale of primary agricultural products [1] - Additional activities include the wholesale and retail of fresh eggs and livestock trading [1] - The company can conduct investment activities with its own funds, except for projects that require approval [1]

Core Insights - Shanghai Heshengjiamei Biotechnology Co., Ltd. has been established with a registered capital of 100,000 RMB [1] Company Overview - The legal representative of the company is Xue Qiang [1] - The company operates in various sectors including technology services, biotechnology material research and development, and sales of cosmetics and daily necessities [1] Business Scope - General projects include technology services, development, consulting, and promotion, as well as research on bio-based materials and chemical products [1] - The company is involved in the wholesale and retail of cosmetics, agricultural product sales, and supply chain management services [1] - Licensed activities include hairdressing and beauty services, which require approval from relevant authorities before operation [1]

Core Viewpoint - Suzhou Zui Zhixing Biotechnology Co., Ltd. has been established with a registered capital of 1 million RMB, focusing on fermentation process optimization and agricultural product trading [1] Group 1: Company Overview - The legal representative of the company is Wang Peter [1] - The registered capital of the company is 1 million RMB [1] Group 2: Business Scope - The company engages in general business projects including fermentation process optimization technology research and grain purchasing [1] - It is involved in wholesale and retail of edible agricultural products, excluding licensed businesses [1] - Licensed operations include the production of alcoholic beverages and grain processed food, which require approval from relevant authorities before commencement [1]

Group 1 - Harbin Yucheng Biotechnology Co., Ltd. has been established with a registered capital of 20 million yuan [1] - The legal representative of the company is Huang Bailin [1] - The business scope includes research and development of biochemicals, biopesticides, wholesale and retail of cosmetics [1] Group 2 - The company is wholly owned by Harbin Sanlian (002900) [1]

主要股东信息显示，安进生物技术咨询（上海）有限公司由安进亚洲控股有限公司持股100%。 安进生物技术咨询（上海）有限公司，成立于2012年，位于上海市，是一家以从事研究和试验发展为主 的企业。企业注册资本100万人民币，实缴资本100万人民币。 通过天眼查大数据分析，安进生物技术咨询（上海）有限公司知识产权方面有商标信息2条，此外企业 还拥有行政许可10个。 11月26日消息，据CDE官网沟通交流公示，于11月26日收到安进生物技术咨询（上海）有限公司申请 的"I类会议"，当前状态"处理中"。 根据《药物研发与技术审评沟通交流管理办法》（2020年第48号通告），沟通交流会议分为Ⅰ类、Ⅱ类 和Ⅲ类会议，就关键阶段重大问题进行沟通交流。Ⅰ类会议一般安排在申请后30日内召开，系指为解决 药物临床试验过程中遇到的重大安全性问题和突破性治疗药物研发过程中的重大技术问题，或其他规定 情形，而召开的会议。 来源：市场资讯 ...